TD Cowen and Truist Financial boosted their price objectives for DaVita shares on June 17, 2026.
1 report, 1 independent
Updated Jun 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TD Cowen and Truist Financial boosted their price objectives for DaVita shares on June 17, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
TD Cowen
American investment bank
-
DaVita
renal dialysis center chain based in the United States
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
Related events
- TD Cowen issued research notes on GE Vernova stock on July 1, 2026.
- TD Cowen raised its price target and issued a buy rating for Globe Life.
- Truist Financial set a $90.00 price target on Edwards Lifesciences shares, and TD Cowen reaffirmed its buy rating and raised the price objective.
- TD Cowen provided analyst ratings and price targets for Werner Enterprises, while Citigroup also lifted its price target based on company performance.
- Financial institutions made various moves on June 18, 2026, including TD Cowen lowering its price objective, Citigroup raising its target, and Royal Bank of Canada increasing its target price. Separately, Man Group reduced its stock holdings.